Sign in
4

Changes in Ownership

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-24-125547

Interim CEO & General Counsel gave up 4,426 shares (to pay taxes)

  • Interim CEO & General Counsel acquired 10,417 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2024-12-02 Option exercise +10,417 214,662 D: show line 1 in the form
Vogt Frederick G Interim CEO & General Counsel 2024-12-02 Shares withheld for taxes −4,426 $9.07 $40,144 210,236 D: show line 2 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Vogt Frederick G Interim CEO & General Counsel 2024-12-02 Option exercise · Restricted Stock Units −10,417 52,087 D: show line 3 in the form
Loading xslF345X05/tm2430163-3_4seq1.xml…